ATE232531T1 - Heterobizyklische derivate - Google Patents
Heterobizyklische derivateInfo
- Publication number
- ATE232531T1 ATE232531T1 AT95924526T AT95924526T ATE232531T1 AT E232531 T1 ATE232531 T1 AT E232531T1 AT 95924526 T AT95924526 T AT 95924526T AT 95924526 T AT95924526 T AT 95924526T AT E232531 T1 ATE232531 T1 AT E232531T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- suitable substituent
- aryl
- heterobicyclic derivatives
- heterocyclic group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9413975A GB9413975D0 (en) | 1994-07-11 | 1994-07-11 | New heterobicyclic derivatives |
PCT/JP1995/001366 WO1996001825A1 (en) | 1994-07-11 | 1995-07-10 | Heterobicyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE232531T1 true ATE232531T1 (de) | 2003-02-15 |
Family
ID=10758154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95924526T ATE232531T1 (de) | 1994-07-11 | 1995-07-10 | Heterobizyklische derivate |
Country Status (19)
Country | Link |
---|---|
US (2) | US6426345B1 (de) |
EP (2) | EP0770079B1 (de) |
JP (1) | JP3206003B2 (de) |
KR (1) | KR100394761B1 (de) |
CN (2) | CN1051548C (de) |
AT (1) | ATE232531T1 (de) |
AU (1) | AU698133B2 (de) |
CA (1) | CA2194872A1 (de) |
DE (1) | DE69529614T2 (de) |
DK (1) | DK0770079T3 (de) |
ES (1) | ES2187561T3 (de) |
GB (1) | GB9413975D0 (de) |
HK (1) | HK1004483A1 (de) |
HU (1) | HUT77353A (de) |
MX (1) | MX9700308A (de) |
PT (1) | PT770079E (de) |
RU (2) | RU2170737C2 (de) |
TW (1) | TW383307B (de) |
WO (1) | WO1996001825A1 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
GB9816837D0 (en) * | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
US6235887B1 (en) | 1991-11-26 | 2001-05-22 | Isis Pharmaceuticals, Inc. | Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines |
US6517834B1 (en) | 1995-08-04 | 2003-02-11 | Geron Corporation | Purified telomerase |
US6545133B1 (en) | 1995-08-04 | 2003-04-08 | Geron Corporation | Methods for purifying telomerase |
GB9526558D0 (en) * | 1995-12-27 | 1996-02-28 | Fujisawa Pharmaceutical Co | Heterobicyclic derivatives |
SE9603283D0 (sv) * | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
DE19710609A1 (de) | 1997-03-14 | 1998-09-17 | Bayer Ag | Substituierte Aminosalicylsäureamide |
AR017200A1 (es) | 1997-12-23 | 2001-08-22 | Astrazeneca Ab | Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos |
SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
CN1328555A (zh) * | 1998-09-29 | 2001-12-26 | 藤泽药品工业株式会社 | 吡啶并吡嗪化合物的新的盐及其结晶 |
US6548514B1 (en) * | 1999-03-17 | 2003-04-15 | Astrazeneca Ab | Amide derivatives |
US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
DE60043318D1 (de) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistische kombination von pumafentrine und salmeterol |
ATE362926T1 (de) | 2000-01-20 | 2007-06-15 | Eisai R&D Man Co Ltd | Stickstoffhaltige cyclische verbindungen und sie enthaltende pharmazeutische zubereitungen |
DK1257550T3 (da) * | 2000-02-04 | 2006-03-27 | Portola Pharm Inc | Blodplade-ADP-receptor-inhibitor |
US6906063B2 (en) | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
GB0006133D0 (en) * | 2000-03-14 | 2000-05-03 | Smithkline Beecham Plc | Novel pharmaceutical |
EP2329842A3 (de) | 2000-05-12 | 2011-07-27 | Immunex Corporation | Interleukin-1 Inhibitoren zur Behandlung von Erkrankungen |
JP4160295B2 (ja) * | 2000-12-08 | 2008-10-01 | 武田薬品工業株式会社 | 3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途 |
JP5025057B2 (ja) * | 2001-05-10 | 2012-09-12 | 株式会社半導体エネルギー研究所 | 半導体装置の作製方法 |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
KR100490970B1 (ko) * | 2002-03-22 | 2005-05-24 | 씨제이 주식회사 | 신규 피리도[2,3-d]피리미딘 카르보알데히드 옥심계PDE Ⅳ 효소 저해 화합물 및 이의 제조방법 |
US8450302B2 (en) | 2002-08-02 | 2013-05-28 | Ab Science | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
PT1525200E (pt) | 2002-08-02 | 2008-01-10 | Ab Science | 2-(3-aminoaril)amino-4-aril-tiazóis para o tratamento de doenças |
BR0314364A (pt) * | 2002-09-16 | 2005-07-19 | Alcon Mfg Ltd | Uso de inibidores de pde iv para tratar angiogênese |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
EP2308848A1 (de) | 2003-02-03 | 2011-04-13 | Janssen Pharmaceutica NV | Chinolin-Amid-Derivate als Modulatoren von Vanilloid-VR1-Rezeptoren |
US7892563B2 (en) | 2003-05-20 | 2011-02-22 | Wyeth Holdings Corporation | Methods for treatment of severe acute respiratory syndrome (SARS) |
DE10323345A1 (de) * | 2003-05-23 | 2004-12-16 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren |
DE502004008322D1 (de) * | 2003-05-23 | 2008-12-04 | Aterna Zentaris Gmbh | Neue pyridopyrazine und deren verwendung als modulatoren von kinasen |
US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
EP1729771B1 (de) * | 2004-03-22 | 2009-10-14 | Eli Lilly & Company | Pyridyl-derivate und ihre verwendung als mglu5-rezeptorantagonisten |
CA2603830A1 (en) * | 2005-05-24 | 2006-11-30 | Pharmacia & Upjohn Co Llc | PYRIDINE [2,3-B] PYRAZINONES |
EP1746096A1 (de) * | 2005-07-15 | 2007-01-24 | 4Sc Ag | 2-Arylbenzothiazol-Analoge zur Verwendung als Antikrebsmittel |
NZ567747A (en) | 2005-11-03 | 2011-11-25 | Portola Pharm Inc | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
RU2515944C9 (ru) * | 2005-11-11 | 2014-07-20 | Этерна Центарис ГмбХ | ПРОИЗВОДНЫЕ ПИРИДОПИРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ФИЗИОЛОГИЧЕСКИХ И/ИЛИ ПАТОФИЗИОЛОГИЧЕСКИХ СОСТОЯНИЙ ПОСРЕДСТВОМ ИНГИБИРОВАНИЯ ФЕРМЕНТОВ ERK, ERK1, ERK2, PI3K, PI3Kальфа, PI3Kбета, PI3Kгамма, PI3Kдельта, PI3K-С2альфа, PI3K-С2бета, PI3K-Vps34р (ВАРИАНТЫ) |
US20080280891A1 (en) * | 2006-06-27 | 2008-11-13 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
WO2008008059A1 (en) * | 2006-07-12 | 2008-01-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents ans uses thereof |
US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
EP2527360B1 (de) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
MX2010009577A (es) | 2008-03-05 | 2010-09-24 | Merck Patent Gmbh | Derivados de piridopirazinona que estimulan la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. |
FR2930552B1 (fr) * | 2008-04-24 | 2012-10-12 | Centre Nat Rech Scient | N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
EP4424697A2 (de) | 2013-06-05 | 2024-09-04 | Bausch Health Ireland Limited | Ultrareine agonisten der guanylatcyclase c, verfahren zur herstellung und verwendung davon |
IL280864B2 (en) | 2013-08-09 | 2024-03-01 | Ardelyx Inc | Compounds and methods for inhibiting phosphate transport |
GB201317609D0 (en) | 2013-10-04 | 2013-11-20 | Cancer Rec Tech Ltd | Inhibitor compounds |
US20170314007A1 (en) * | 2014-09-30 | 2017-11-02 | China Three Gorges University | Medicament design pocket of ornithine decarboxylase and application of medicament design pocket |
CN104739820B (zh) * | 2014-09-30 | 2017-02-15 | 三峡大学 | 一种小分子抑制剂及在抑制鸟氨酸脱羧酶上的应用 |
GB201505658D0 (en) | 2015-04-01 | 2015-05-13 | Cancer Rec Tech Ltd | Inhibitor compounds |
GB201617103D0 (en) | 2016-10-07 | 2016-11-23 | Cancer Research Technology Limited | Compound |
EP3972599A1 (de) | 2019-05-21 | 2022-03-30 | Ardelyx, Inc. | Kombination zur senkung des serum-phosphatspiegels bei einem patienten |
CN118721925A (zh) * | 2024-09-03 | 2024-10-01 | 四川固朔新材料有限公司 | 一种电子多晶硅多用功能性内包装材料及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA794209B (en) * | 1978-08-15 | 1980-07-30 | Fisons Ltd | Pharmaceutically active heterocyclic compounds |
EP0008864A1 (de) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazin- und Chinoxalinderivate, Verfahren zu ihrer Herstellung, und sie enthaltende pharmazeutische Zusammensetzungen |
GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
GB9526558D0 (en) | 1995-12-27 | 1996-02-28 | Fujisawa Pharmaceutical Co | Heterobicyclic derivatives |
-
1994
- 1994-07-11 GB GB9413975A patent/GB9413975D0/en active Pending
-
1995
- 1995-07-10 WO PCT/JP1995/001366 patent/WO1996001825A1/en active IP Right Grant
- 1995-07-10 ES ES95924526T patent/ES2187561T3/es not_active Expired - Lifetime
- 1995-07-10 KR KR1019970700113A patent/KR100394761B1/ko not_active IP Right Cessation
- 1995-07-10 CN CN95194959A patent/CN1051548C/zh not_active Expired - Fee Related
- 1995-07-10 AU AU28992/95A patent/AU698133B2/en not_active Ceased
- 1995-07-10 EP EP95924526A patent/EP0770079B1/de not_active Expired - Lifetime
- 1995-07-10 US US08/793,451 patent/US6426345B1/en not_active Expired - Fee Related
- 1995-07-10 EP EP98120297A patent/EP0920867A1/de not_active Withdrawn
- 1995-07-10 DE DE69529614T patent/DE69529614T2/de not_active Expired - Fee Related
- 1995-07-10 DK DK95924526T patent/DK0770079T3/da active
- 1995-07-10 MX MX9700308A patent/MX9700308A/es unknown
- 1995-07-10 CA CA002194872A patent/CA2194872A1/en not_active Abandoned
- 1995-07-10 AT AT95924526T patent/ATE232531T1/de not_active IP Right Cessation
- 1995-07-10 JP JP50422696A patent/JP3206003B2/ja not_active Expired - Fee Related
- 1995-07-10 PT PT95924526T patent/PT770079E/pt unknown
- 1995-07-10 RU RU97101882/04A patent/RU2170737C2/ru not_active IP Right Cessation
- 1995-07-10 HU HU9700068A patent/HUT77353A/hu unknown
- 1995-07-11 TW TW084107168A patent/TW383307B/zh not_active IP Right Cessation
-
1998
- 1998-05-01 HK HK98103728A patent/HK1004483A1/xx not_active IP Right Cessation
-
1999
- 1999-07-29 CN CN99111945A patent/CN1250776A/zh active Pending
-
2001
- 2001-03-22 RU RU2001107897/14A patent/RU2001107897A/ru not_active Application Discontinuation
-
2002
- 2002-01-18 US US10/050,855 patent/US6727245B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0770079A1 (de) | 1997-05-02 |
EP0920867A1 (de) | 1999-06-09 |
RU2170737C2 (ru) | 2001-07-20 |
WO1996001825A1 (en) | 1996-01-25 |
DK0770079T3 (da) | 2003-06-10 |
TW383307B (en) | 2000-03-01 |
GB9413975D0 (en) | 1994-08-31 |
HK1004483A1 (en) | 1998-11-27 |
ES2187561T3 (es) | 2003-06-16 |
CN1250776A (zh) | 2000-04-19 |
US6426345B1 (en) | 2002-07-30 |
AU2899295A (en) | 1996-02-09 |
AU698133B2 (en) | 1998-10-22 |
CN1157617A (zh) | 1997-08-20 |
DE69529614D1 (de) | 2003-03-20 |
JPH10502630A (ja) | 1998-03-10 |
US6727245B2 (en) | 2004-04-27 |
DE69529614T2 (de) | 2003-07-03 |
MX9700308A (es) | 1997-05-31 |
JP3206003B2 (ja) | 2001-09-04 |
HUT77353A (hu) | 1998-03-30 |
US20020107251A1 (en) | 2002-08-08 |
KR100394761B1 (ko) | 2003-11-20 |
CA2194872A1 (en) | 1996-01-25 |
EP0770079B1 (de) | 2003-02-12 |
CN1051548C (zh) | 2000-04-19 |
RU2001107897A (ru) | 2003-01-20 |
PT770079E (pt) | 2003-06-30 |
HU9700068D0 (en) | 1997-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE232531T1 (de) | Heterobizyklische derivate | |
NO882608D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer. | |
NO304946B1 (no) | Xantinderivat samt dets anvendelse | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
ATE194335T1 (de) | 4,5-diaryloxazol-derivate | |
DK0632036T3 (da) | Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser | |
HK1001835A1 (en) | Therapeutic agents for use in the treatment of parkinson's disease | |
EP0779074A4 (de) | Wirkstoff zum schutz für organ oder gewebe | |
DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
ATE232515T1 (de) | 3-(bis-substituierte-phenylmethylen)oxindol- derivate | |
ATE504572T1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
ATE263183T1 (de) | A-500359-derivate | |
NO893039L (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. | |
NO894325L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0770079 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |